PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
8262669-0	1994	Receptor-mediated cytotoxicity of alpha-MSH fragments containing melphalan in a human melanoma cell line.	Melphalan	65-74	proopiomelanocortin	Homo sapiens	34-43	
8019062-1	1994	Two different chlorinated drugs, chlorambucil and melphalan, have been linked to the carrier alpha-melanocyte-stimulating hormone at the end of the solid-phase peptide synthesis of the hormone.	Melphalan	50-59	proopiomelanocortin	Homo sapiens	93-129	
1668532-0	1991	Human melanoma targeting with alpha-MSH-melphalan conjugate.	Melphalan	40-49	proopiomelanocortin	Homo sapiens	30-39	
1668532-6	1991	alpha-MSH receptor recognition properties also remained unchanged with a better apparent affinity of the conjugate probably due to the alkylating activity of melphalan itself.	Melphalan	158-167	proopiomelanocortin	Homo sapiens	0-9	
1668532-7	1991	Using human melanoma dendritic cells expressing more than 10,000 alpha-MSH binding sites per cell as an in vitro model, we were able to demonstrate higher cytotoxicities as compared to melphalan-treated cells.	Melphalan	185-194	proopiomelanocortin	Homo sapiens	65-74	
2171755-1	1990	alpha-MSH fragments containing melphalan were tested in vivo on L1210 leukemia and on human amelanotic melanoma xenograft in mice and in vitro on human amelanotic melanoma cell lines.	Melphalan	31-40	proopiomelanocortin	Homo sapiens	0-9	
2177734-1	1990	For chemical affinity labeling of the melanotropin receptor several alpha-MSH fragments containing phenylalanine mustard were synthesized in solution.	Melphalan	99-120	proopiomelanocortin	Homo sapiens	68-77